Literature DB >> 16604035

[Tuberculous pneumothorax. Retrospective study of 23 cases in Tunisia].

S Mezghani1, A Abdelghani, H Njima, A Hayouni, A Garrouche, N Klabi, M Benzarti, M Jerray.   

Abstract

The tubercular pneumothorax is a rare and severe form of tuberculosis which persists in Tunisia. We reviewed retrospectively our experience at the Pneumology-Allergology Department of the Sousse Hospital with 23 cases of tubercular pneumothorax observed between 1985 and 2003. The suggestive symptom, pneumothorax, always occurred within a context poor general health and fever. The chest roentgengraph showed pneumothorax (n=8) or hydropneumothorax (n=15), and pulmonary lesions associated in 82.5% of patients. Bacteriological proof was obtained in 21 cases; in the two other patients, histological examination of the surgical specimen was highly suggestive of tuberculosis. Treatment associated antitubercular chemotherapy in compliance with the National Plan of against Tuberculosis (n=23), chest drainage (n=21) and respiratory physiotherapy (n=18). Five patients underwent surgery: pleural decortications (n=3), pulmonary resections (n=2). Two were lost to follow-up. The course was favourable in 78% of patients; there were two cases of partitioned pyopneumothorax and one post-operative death. In our experience, tubercular pneumothorax was always associated with active cavitated tuberculosis. The course was almost favorable with antitubercular chemotherapy and chest drainage.

Entities:  

Mesh:

Year:  2006        PMID: 16604035     DOI: 10.1016/s0761-8417(06)75407-4

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  2 in total

1.  [Tuberculous pyopneumothorax: about 18 cases].

Authors:  Souhi Hicham; El Ouazzani Hanane; Janah Hicham; Rhorfi Ismaïl; Abid Ahmed
Journal:  Pan Afr Med J       Date:  2016-05-09

2.  Legionella community-acquired pneumonia (CAP) presenting with spontaneous bilateral pneumothoraces.

Authors:  Burke A Cunha; Francisco Miled Pherez; Yelda Nouri
Journal:  Heart Lung       Date:  2008 May-Jun       Impact factor: 2.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.